相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Identifying potential targets for prevention and treatment of amyotrophic lateral sclerosis based on a screen of medicare prescription drugs
Ruth M. Pfeiffer et al.
AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION (2020)
Mendelian Randomization-A Journey From Obscurity to Center Stage With a Few Potholes Along the Way
Sara Bandres-Ciga et al.
JAMA NEUROLOGY (2020)
The protective role of pre-morbid type 2 diabetes in patients with amyotrophic lateral sclerosis: a center-based survey in China
Linjing Zhang et al.
AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION (2020)
Shared polygenic risk and causal inferences in amyotrophic lateral sclerosis
Sara Bandres-Ciga et al.
ANNALS OF NEUROLOGY (2019)
TDP-43 regulates early-phase insulin secretion via CaV1.2-mediated exocytosis in islets
Kunihiko Araki et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Type II diabetes mellitus and the incidence of amyotrophic lateral sclerosis
Ching-Piao Tsai et al.
JOURNAL OF NEUROLOGY (2019)
Metabolic Alteration and Amyotrophic Lateral Sclerosis Outcome: A Systematic Review
Mariana Dutra Brito et al.
FRONTIERS IN NEUROLOGY (2019)
Causal association of type 2 diabetes with amyotrophic lateral sclerosis: new evidence from Mendelian randomization using GWAS summary statistics
Ping Zeng et al.
BMC MEDICINE (2019)
Early weight loss in amyotrophic lateral sclerosis: outcome relevance and clinical correlates in a population-based cohort
Cristina Moglia et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2019)
IgGs from patients with amyotrophic lateral sclerosis and diabetes target Cavα2δ1 subunits impairing islet cell function and survival
Yue Shi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Diabetes mellitus and amyotrophic lateral sclerosis: time to bridge the gap between the bench and the bedside
A. Jawaid et al.
EUROPEAN JOURNAL OF NEUROLOGY (2018)
The role of pre-morbid diabetes on developing amyotrophic lateral sclerosis
F. D'Ovidio et al.
EUROPEAN JOURNAL OF NEUROLOGY (2018)
AMPK: guardian of metabolism and mitochondrial homeostasis
Sebastien Herzig et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2018)
Cardiovascular diseases may play a negative role in the prognosis of amyotrophic lateral sclerosis
J. Mandrioli et al.
EUROPEAN JOURNAL OF NEUROLOGY (2018)
Paradox of amyotrophic lateral sclerosis and energy metabolism
Rebekah M. Ahmed et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2018)
Novel genes associated with amyotrophic lateral sclerosis: diagnostic and clinical implications
Ruth Chia et al.
LANCET NEUROLOGY (2018)
Association of Serum Retinol-Binding Protein 4 Concentration With Risk for and Prognosis of Amyotrophic Lateral Sclerosis
Angela Rosenbohm et al.
JAMA NEUROLOGY (2018)
Factors predicting survival in ALS: a multicenter Italian study
Andrea Calvo et al.
JOURNAL OF NEUROLOGY (2017)
Blood hemoglobin A1c levels and amyotrophic lateral sclerosis survival
Qian-Qian Wei et al.
MOLECULAR NEURODEGENERATION (2017)
Insulin-like growth factor 1 in diabetic neuropathy and amyotrophic lateral sclerosis
Stefanie Rauskolb et al.
NEUROBIOLOGY OF DISEASE (2017)
Influence of arterial hypertension, type 2 diabetes and cardiovascular risk factors on ALS outcome: a population-based study
Cristina Moglia et al.
AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION (2017)
Response to the letter Type 2 diabetes and amyotrophic lateral sclerosis'
D. Mariosa et al.
EUROPEAN JOURNAL OF NEUROLOGY (2016)
Type 2 diabetes and amyotrophic lateral sclerosis
T. Kawada
EUROPEAN JOURNAL OF NEUROLOGY (2016)
Retinoids and motor neuron disease: Potential role in amyotrophic lateral sclerosis
Javier Riancho et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2016)
TBK1 is associated with ALS and ALS-FTD in Sardinian patients
Giuseppe Borghero et al.
NEUROBIOLOGY OF AGING (2016)
Can commonly prescribed drugs be repurposed for the prevention or treatment of Alzheimer's and other neurodegenerative diseases? Protocol for an observational cohort study in the UK Clinical Practice Research Datalink
Venexia M. Walker et al.
BMJ OPEN (2016)
Antecedent Disease and Amyotrophic Lateral Sclerosis: What Is Protecting Whom?
Sabrina K. Hollinger et al.
FRONTIERS IN NEUROLOGY (2016)
Diabetes mellitus in amyotrophic lateral sclerosis: Dr Jekyll or Mr Hyde?
A. Jawaid et al.
EUROPEAN JOURNAL OF NEUROLOGY (2015)
Association between diabetes and amyotrophic lateral sclerosis in Sweden
D. Mariosa et al.
EUROPEAN JOURNAL OF NEUROLOGY (2015)
Aberrant activation of AMP-activated protein kinase contributes to the abnormal distribution of HuR in amyotrophic lateral sclerosis
Yu-Ju Liu et al.
FEBS LETTERS (2015)
Risk of Amyotrophic Lateral Sclerosis in Patients With Diabetes: A Nationwide Population-Based Cohort Study
Yu Sun et al.
JOURNAL OF EPIDEMIOLOGY (2015)
AMPK-mediated regulation of neuronal metabolism and function in brain diseases
Yu-Ju Liu et al.
JOURNAL OF NEUROGENETICS (2015)
PRE-MORBID TYPE 2 DIABETES MELLITUS AS A PROGNOSTIC FACTOR IN AMYOTROPHIC LATERAL SCLEROSIS
Ali Jawaid et al.
MUSCLE & NERVE (2015)
PRE-MORBID TYPE 2 DIABETES MELLITUS AS A PROGNOSTIC FACTOR IN AMYOTROPHIC LATERAL SCLEROSIS REPLY
Sabrina Paganoni et al.
MUSCLE & NERVE (2015)
Pre-morbid type 2 diabetes mellitus is not a prognostic factor in amyotrophic lateral sclerosis
Sabrina Paganoni et al.
MUSCLE & NERVE (2015)
Are diabetes and amyotrophic lateral sclerosis related?
Giancarlo Logroscino
NATURE REVIEWS NEUROLOGY (2015)
Preconditioning with latrepirdine, an adenosine 5′-monophosphate-activated protein kinase activator, delays amyotrophic lateral sclerosis progression in SOD1G93A mice
Karen S. Coughlan et al.
NEUROBIOLOGY OF AGING (2015)
Antecedent Disease Is Less Prevalent in Amyotrophic Lateral Sclerosis
Cassie S. Mitchell et al.
NEURODEGENERATIVE DISEASES (2015)
Relation between BMI and Diabetes Mellitus and Its Complications among US Older Adults
Natallia Gray et al.
SOUTHERN MEDICAL JOURNAL (2015)
Diabetes Mellitus, Obesity, and Diagnosis of Amyotrophic Lateral Sclerosis A Population-Based Study
Marianthi-Anna Kioumourtzoglou et al.
JAMA NEUROLOGY (2015)
Risk factors for amyotrophic lateral sclerosis
Caroline Ingre et al.
CLINICAL EPIDEMIOLOGY (2015)
Activation of AMP-activated protein kinase α1 mediates mislocalization of TDP-43 in amyotrophic lateral sclerosis
Yu-Ju Liu et al.
HUMAN MOLECULAR GENETICS (2015)
Effects of diet on adenosine monophosphate-activated protein kinase activity and disease progression in an amyotrophic lateral sclerosis model
Zichun Zhao et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2015)
Genetically altering organismal metabolism by leptin-deficiency benefits a mouse model of amyotrophic lateral sclerosis
Maria A. Lim et al.
HUMAN MOLECULAR GENETICS (2014)
Prior medical conditions and the risk of amyotrophic lateral sclerosis
Meinie Seelen et al.
JOURNAL OF NEUROLOGY (2014)
Hypercaloric enteral nutrition in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled phase 2 trial
Anne-Marie Wills et al.
LANCET (2014)
ER stress and unfolded protein response in amyotrophic lateral sclerosis-a controversial role of protein disulphide isomerase
Merja Jaronen et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2014)
12q24 locus association with type 1 diabetes: SH2B3 or ATXN2 ?
Georg Auburger et al.
WORLD JOURNAL OF DIABETES (2014)
ER stress-induced cell death mechanisms
Renata Sano et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2013)
Sirtuins as therapeutic targets of ALS
Giulio Maria Pasinetti et al.
CELL RESEARCH (2013)
Sirtuin deacetylases in neurodegenerative diseases of aging
Adrianna Z. Herskovits et al.
CELL RESEARCH (2013)
Diagnosis and Classification of Diabetes Mellitus
DIABETES CARE (2013)
Prevalence and prognostic impact of comorbidities in amyotrophic lateral sclerosis
S. Koerner et al.
EUROPEAN JOURNAL OF NEUROLOGY (2013)
Plasma Progranulin Concentrations Are Increased in Patients with Type 2 Diabetes and Obesity and Correlated with Insulin Resistance
Hua Qu et al.
MEDIATORS OF INFLAMMATION (2013)
Mutant SOD1G93A triggers mitochondrial fragmentation in spinal cord motor neurons: Neuroprotection by SIRT3 and PGC-1α
Wenjun Song et al.
NEUROBIOLOGY OF DISEASE (2013)
Autoimmune disease preceding amyotrophic lateral sclerosis An epidemiologic study
Martin R. Turner et al.
NEUROLOGY (2013)
Genetics of type 2 diabetes
Omar Ali
WORLD JOURNAL OF DIABETES (2013)
The Association Between IGF-I and Insulin Resistance A general population study in Danish adults
Nele Friedrich et al.
DIABETES CARE (2012)
A Randomized, Double Blind, Placebo-Controlled Trial of Pioglitazone in Combination with Riluzole in Amyotrophic Lateral Sclerosis
Luc Dupuis et al.
PLOS ONE (2012)
ATXN2 and Its Neighbouring Gene SH2B3 Are Associated with Increased ALS Risk in the Turkish Population
Suna Lahut et al.
PLOS ONE (2012)
Recombinant human insulin-like growth factor I (rhIGF-I) for the treatment of amyotrophic lateral sclerosis/motor neuron disease
Michel Beauverd et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2012)
Amyotrophic lateral sclerosis
Matthew C. Kiernan et al.
LANCET (2011)
Energy metabolism in amyotrophic lateral sclerosis
Luc Dupuis et al.
LANCET NEUROLOGY (2011)
BODY MASS INDEX, NOT DYSLIPIDEMIA, IS AN INDEPENDENT PREDICTOR OF SURVIVAL IN AMYOTROPHIC LATERAL SCLEROSIS
Sabrina Paganoni et al.
MUSCLE & NERVE (2011)
Metformin Treatment Has No Beneficial Effect in a Dose-Response Survival Study in the SOD1G93A Mouse Model of ALS and Is Harmful in Female Mice
Hannah M. Kaneb et al.
PLOS ONE (2011)
ALS disease onset may occur later in patients with pre-morbid diabetes mellitus
A. Jawaid et al.
EUROPEAN JOURNAL OF NEUROLOGY (2010)
The metabolic syndrome
Robert H. Eckel et al.
LANCET (2010)
Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS
Andrew C. Elden et al.
NATURE (2010)
Progranulin is Neurotrophic In Vivo and Protects against a Mutant TDP-43 Induced Axonopathy
Angela S. Laird et al.
PLOS ONE (2010)
TANK-binding kinase 1 mediates phosphorylation of insulin receptor at serine residue 994: a potential link between inflammation and insulin resistance
Marina C. Munoz et al.
JOURNAL OF ENDOCRINOLOGY (2009)
Hypermetabolism in ALS patients: an early and persistent phenomenon
C. Bouteloup et al.
JOURNAL OF NEUROLOGY (2009)
ER Stress and Unfolded Protein Response in Amyotrophic Lateral Sclerosis
Kohsuke Kanekura et al.
MOLECULAR NEUROBIOLOGY (2009)
Lower serum lipid levels are related to respiratory impairment in patients with ALS
A. Chio et al.
NEUROLOGY (2009)
Subcutaneous IGF-1 is not beneficial in 2-year ALS trial
E. J. Sorenson et al.
NEUROLOGY (2008)
Nutritional status and risk of amyotrophic lateral sclerosis in Japan
Kazushi Okamoto et al.
AMYOTROPHIC LATERAL SCLEROSIS (2007)
Comparison of the growth hormone, IGF-1 and insulin in cerebrospinal fluid and serum between patients with motor neuron disease and healthy controls
E. Bilic et al.
EUROPEAN JOURNAL OF NEUROLOGY (2006)
A ketogenic diet as a potential novel therapeutic intervention in amyotrophic lateral sclerosis
Zhong Zhao et al.
BMC NEUROSCIENCE (2006)
Evidence for defective energy homeostasis in amyotrophic lateral sclerosis:: benefit of a high-energy diet in a transgenic mouse
L Dupuis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
分享论文
